The emerging approach of the medication represents a major development in the management of diabetes mellitus type 2. Distinct from existing medications, tirzepatide affects dual pathways – GLP-1 and https://tirzepatidepeptide499527.newsbloger.com/42638017/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment